The mechanism: The Prohibiting Russian Uranium Imports Act phases out Russian enriched uranium through 2040, and Washington backed the ban with cash, not just prohibition. On January 5, 2026, the Department of Energy selected Centrus subsidiary American Centrifuge Operating for a task order to expand commercial-scale HALEU (high-assay low-enriched uranium) production at Piketon, Ohio — a deal that converted into a signed $900 million fixed-price contract on July 1, 2026, worth over $1 billion including options. That's not a subsidy check; it's DOE buying enrichment capacity the country doesn't otherwise have, because Centrus is the only U.S. company licensed to produce HALEU domestically. Meanwhile, the same ban tightens the raw-uranium and conversion side of the chain, where Russia (via Rosatom) was a meaningful global supplier — and that scarcity flows to miners, not enrichers.
Energy
Centrus vs. Cameco: Washington's Russian Uranium Ban Splits the Nuclear Fuel Chain
The Prohibiting Russian Uranium Imports Act and new DOE HALEU contracting build out one company's enrichment plant while pushing raw uranium demand toward a different set of miners — and they're not the same stock.

1-YEAR MOVE
LEU
▼54.3%
CCJ
▲12.4%
| Ticker | Company | 1-year change |
|---|---|---|
| LEU | Centrus Energy | −54.3% |
| CCJ | Cameco | +12.4% |